Lotte Fine Chemical stock (KR7004000003): Q1 profit surge on strong revenue

Lotte Fine Chemical reported KRW 510.7 billion in Q1 2026 revenue and KRW 32.7 billion operating profit, up significantly year-over-year, as part of Lotte Group's chemical recovery.

Lotte Fine Chemical, a key player in specialty chemicals, delivered strong Q1 2026 results with revenue of KRW 510.7 billion and operating profit of KRW 32.7 billion (6.4% margin), according to provisional figures released on May 11, 2026, via FNTimes as of 05/14/2026. This performance marks a robust turnaround amid parent Lotte Chemical's return to profitability after 10 quarters of losses.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Lotte Fine Chemical Co., Ltd.
• Sector/industry: Specialty Chemicals
• Headquarters/country: South Korea
• Core markets: Asia, Global
• Key revenue drivers: HPMC, cellulosic polymers, fine chemicals
• Home exchange/listing venue: Korea Exchange (KR7004000003)
• Trading currency: KRW

Lotte Fine Chemical: core business model

Lotte Fine Chemical specializes in high-value fine chemicals, including hydroxypropyl methylcellulose (HPMC), cellulosic polymers, and TMAC products. As a subsidiary of South Korea's Lotte Group, it focuses on functional materials for pharmaceuticals, construction, and electronics. The company produces HPMC used in drug formulations and building materials, positioning it in growing global markets, per industry reports as of 2026 from Zhiwei Chem as of 05/14/2026.

Its business model emphasizes expansion in high-margin products like engineering plastics and specialty polymers. Recent analyst upgrades, such as a target price boost to 86,000 KRW tied to TMAC capacity bets, highlight growth potential, according to BigGo Finance as of 05/14/2026.

Main revenue and product drivers for Lotte Fine Chemical

Key drivers include HPMC and cellulosic polymers, with Lotte Fine Chemical listed among top global players alongside Eastman Chemical, per Spherical Insights 2026 report. Q1 2026 revenue of KRW 510.7 billion reflects strength in these segments, supporting parent Lotte Chemical's high value-added push.

The company also contributes to methylene chloride and aluminum silicate markets, with exposure to expanding sectors like pharmaceuticals and construction, relevant for US investors tracking Asian supply chains.

Industry trends and competitive position

The global cellulosic polymers market is set for growth through 2035, driven by demand in pharma and personal care. Lotte Fine Chemical competes with Eastman and Ashland, leveraging Lotte Group's scale for cost advantages. Its role in HPMC production aligns with rising US construction and drug manufacturing needs.

Why Lotte Fine Chemical matters for US investors

Lotte Fine Chemical offers US investors exposure to Asia's chemical boom, with products integral to US pharma and construction supply chains. Listed on the Korea Exchange, it provides diversification amid US market volatility, with Q1 results signaling resilience in global trade.

Conclusion

Lotte Fine Chemical's Q1 2026 earnings highlight operational strength with solid revenue and profit margins amid group-wide recovery. Expansion in TMAC and polymers positions it for mid-term growth, though chemical sector cycles remain a factor. Investors monitor upcoming capacity ramps and market dynamics.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.